LOS ANGELES, CA / ACCESSWIRE / January 3, 2018 / Ryan Eagle, Principle Investor of XCell Fund, a private equity fund that works with developing companies, is pleased to announce that 2017 has been an ...
Xcell Biosciences announced today that it has expanded its development and commercial efforts around new market opportunities in immunotherapy drug research and development. The ever-growing ...
Two-wheel vehicles are now changing and evolving perhaps faster than ever before, with ambitious startups all over the world ready to shake things up with disruptive designs and technologies. One of ...
SAN FRANCISCO--(BUSINESS WIRE)--Xcell Biosciences Inc. (Xcellbio), an instrumentation company focused on cell and gene therapy applications, today announced it has achieved key milestones in its R&D ...
LAUSANNE, Switzerland--(BUSINESS WIRE)--NewBiologix, a technology innovation company pioneering innovative tools enabling efficient, cost-effective, and large-scale production of viral vectors for ...
Thermo Fisher Scientific Inc. (NYSE:TMO) ranks among the best CRISPR stocks to buy. On June 24, Thermo Fisher Scientific Inc. (NYSE:TMO) partnered with Xcell Biosciences, an instrumentation firm ...
In recent years, fed-batch biomanufacturing has begun giving way to continuous manufacturing processes, as developers face pressure to balance affordability with high manufacturing quality. Although ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min “This is an opportunity for me ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback